Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer development

Citations Over TimeTop 1% of 2023 papers

Abstract

Hypoxia-induced adenosine creates an immunosuppressive tumor microenvironment (TME) and dampens the efficacy of immune checkpoint inhibitors (ICIs). We found that hypoxia-inducible factor 1 (HIF-1) orchestrates adenosine efflux through two steps in hepatocellular carcinoma (HCC). First, HIF-1 activates transcriptional repressor MXI1, which inhibits adenosine kinase (ADK), resulting in the failure of adenosine phosphorylation to adenosine monophosphate. This leads to adenosine accumulation in hypoxic cancer cells. Second, HIF-1 transcriptionally activates equilibrative nucleoside transporter 4, pumping adenosine into the interstitial space of HCC, elevating extracellular adenosine levels. Multiple in vitro assays demonstrated the immunosuppressive role of adenosine on T cells and myeloid cells. Knockout of ADK in vivo skewed intratumoral immune cells to protumorigenic and promoted tumor progression. Therapeutically, combination treatment of adenosine receptor antagonists and anti-PD-1 prolonged survival of HCC-bearing mice. We illustrated the dual role of hypoxia in establishing an adenosine-mediated immunosuppressive TME and offered a potential therapeutic approach that synergizes with ICIs in HCC.

Related Papers

• → Shaping of monocyte and macrophage function by adenosine receptors(2006)219 cited
• → Inhibition of adenosine kinase increases endogenous adenosine and depresses neuronal activity in hippocampal slices(1994)142 cited
• → Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors(1995)29 cited
• → Adenosine Metabolism(2016)1 cited
• → The effect of adenosine on mRNA expression of hyaluronate synthase in gingival fibroblasts.(2000)1 cited